PMID- 36713973 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230202 IS - 1177-889X (Print) IS - 1177-889X (Electronic) IS - 1177-889X (Linking) VI - 17 DP - 2023 TI - The Relationship Between Social Capital and Hypertension Among Type 2 Diabetes Mellitus Patients: The Moderating Effect of Depressive Symptoms. PG - 209-216 LID - 10.2147/PPA.S396383 [doi] AB - PURPOSE: This study aimed to evaluate the relationship between social capital (SC) and hypertension among type 2 diabetes mellitus (T2DM) patients, considering the moderation effects of depressive symptoms. PATIENTS AND METHODS: A total of 1761 Chinese T2DM patients completed measure scales of social capital and epidemiological survey depression scale (CES-D). The Bootstrap methods PROCESS program is employed to test the moderation model. RESULTS: The prevalence of hypertension among T2DM patients was 39.3%. The SC was negatively correlated with the CES-D score (r=-0.18, P<0.01); the SC was also negatively correlated with diastolic blood pressure (r=-0.05, P<0.05); and the CES-D score was positively correlated with systolic blood pressure (r=0.05, P<0.05). Both logistic regression analysis and the Bootstrap method showed that depressive symptoms weakened the protective effect of SC on hypertension, there existed a moderating effect of depressive symptoms on the relationship between SC and hypertension among T2DM patients. CONCLUSION: Depressive symptoms may be one crucial moderator of the relationship between SC and hypertension in a representative sample of Chinese diabetes patients. The findings indicate that improving SC and mental health may help manage hypertension among T2DM patients. CI - (c) 2023 Yan et al. FAU - Yan, Ning AU - Yan N AD - Heart Centre & Department of Cardiovascular Diseases, General Hospital of Ningxia Medical University, Yinchuan, 750004, People's Republic of China. FAU - Chen, Dapeng AU - Chen D AD - Heart Centre & Department of Cardiovascular Diseases, General Hospital of Ningxia Medical University, Yinchuan, 750004, People's Republic of China. FAU - Pan, Ruiping AU - Pan R AD - Department of Chinese Medicine, The Second People's Hospital of Shizuishan, Shizuishan, 753000, People's Republic of China. FAU - Zhang, Li AU - Zhang L AD - Department of Endocrinology, General Hospital of Ningxia Medical University, Yinchuan, 750004, People's Republic of China. FAU - Ma, Juan AU - Ma J AD - Clinical Medical College, Ningxia Medical University, Yinchuan, 750004, People's Republic of China. FAU - Zhang, Zhengjun AU - Zhang Z AD - Heart Centre & Department of Cardiovascular Diseases, General Hospital of Ningxia Medical University, Yinchuan, 750004, People's Republic of China. FAU - Dang, Yuqi AU - Dang Y AD - Department of Endocrinology, Yinchuan Hospital of Traditional Chinese Medicine, Yinchuan, 750001, People's Republic of China. FAU - Wang, Liqun AU - Wang L AD - Department of Epidemiology and Statistics, School of Public Health and Management, Ningxia Medical University, Yinchuan, 750004, People's Republic of China. FAU - Ma, Xueping AU - Ma X AD - Heart Centre & Department of Cardiovascular Diseases, General Hospital of Ningxia Medical University, Yinchuan, 750004, People's Republic of China. AD - Ningxia Key Laboratory of Vascular Injury and Repair Research, Ningxia Medical University, Yinchuan, 750004, People's Republic of China. FAU - Jia, Shaobin AU - Jia S AD - Heart Centre & Department of Cardiovascular Diseases, General Hospital of Ningxia Medical University, Yinchuan, 750004, People's Republic of China. AD - Ningxia Key Laboratory of Vascular Injury and Repair Research, Ningxia Medical University, Yinchuan, 750004, People's Republic of China. LA - eng PT - Journal Article DEP - 20230121 PL - New Zealand TA - Patient Prefer Adherence JT - Patient preference and adherence JID - 101475748 PMC - PMC9875576 OTO - NOTNLM OT - depressive symptoms OT - hypertension OT - moderation OT - social capital OT - type 2 diabetes mellitus COIS- The authors report no conflicts of interest in this work. EDAT- 2023/01/31 06:00 MHDA- 2023/01/31 06:01 PMCR- 2023/01/21 CRDT- 2023/01/30 04:22 PHST- 2022/11/17 00:00 [received] PHST- 2023/01/07 00:00 [accepted] PHST- 2023/01/30 04:22 [entrez] PHST- 2023/01/31 06:00 [pubmed] PHST- 2023/01/31 06:01 [medline] PHST- 2023/01/21 00:00 [pmc-release] AID - 396383 [pii] AID - 10.2147/PPA.S396383 [doi] PST - epublish SO - Patient Prefer Adherence. 2023 Jan 21;17:209-216. doi: 10.2147/PPA.S396383. eCollection 2023.